Clinical Resources

Management of SARS-CoV-2 Infection and COVID-19

Links curated by Trey Dobson. Please email suggestions to trey.dobson@svhealthcare.org

Strategy and Resources

• National COVID_19 Preparedness Plan
• COVID.gov

Dashboards

• CDC COVID-19 Community Levels
• VT COVID-19 Cases

Mask Resources

• SVMC Masking Requirements.pdf

• Mask Recommendations in Public Indoor Spaces Based on CDC COVID-19 Community Levels.pdf

• Types of Masks and Respirators - CDC

Vaccine and Schedule

• CDC COVID-19 Vaccine Interim Guidance

• COVID-19 Vaccine Eligibility Table for Individuals Without Immunocompromising Conditions.pdf

• COVID-19 Vaccine Eligibility Table for Individuals With Immunocompromising Conditions.pdf

• COVID-19 Vaccine Eligibility Timeline for Individuals Without Immunocompromising Conditions.pdf

• COVID-19 Vaccine Eligibility Timeline for Individuals With Immunocompromising Conditions.pdf

• CDC COVID-19 Vaccine Interim Guidance

• CDC COVID-19 Vaccines Currently Approved or Authorized in the United States

• COVID-19 Vaccine Administration Errors and Deviations

Specific populations

• CDC List of Medical Conditions at High Risk for Severe COVID-19.pdf

• CDC list of moderate to severe immune compromising medical conditions

• CDC list of medical conditions that put one at risk for severe COVID-19

EVUSHELD for prophylaxis in immunocompromised indiviudals

• SVMC order form for Evusheld for preexposure prophylaxis for patients with moderate to severe immune compromise

• CDC list of moderate to severe immune compromising medical conditions

Inpatient Therapeutics

• NIH Treatment Guidelines of COVID-19 Inpatients

• IDSA Treatment Guidelines of COVID-19 Inpatients

• SSCM COIVD-19 Rapid Resources

Outpatient Therapeutics, INCLUDING Paxlovid

• Prescribing/ordering treatment

  • 5 steps to prescribe COVID-19 treatment.pdf

• Treatment is indicated for people at risk of severe COVID-19 when infected with SARS-CoV-2

  • CDC list of medical conditions that put one at risk for severe COVID-19

  • NIH Tier Prioritization of Patients at Highest Risk of Progression to Severe COVID-19.pdf

  • NIH COVID-19 Treatment Guidelines Panel's Statement on Therapies for High-Risk, Nonhospitalized Patients With Mild to Moderate COVID-19

• Test to Treat

  • Locations participating in test to treat

• Pharmacies and health systems dispensing or administering treatment with prescription or provider order

  • Locations dispensing oral treatment or administering infusion treatments

• Overview of treatment options

  • COVID-19 Outpatient Therapeutics Table.pdf

  • COVID-19 Outpatient Therapeutics Algorithm.pdf

  • HHS Comparison of Outpatient Therapies for Mild-Moderate COVID-19 Abbreviated.pdf

• Infusion

  • SVMC order form for infusion treatment of patients testing postitive for SARS-CoV-2 at high risk of severe COVID-19

• Oral antivirals INCLUDING Paxlovid

  • FDA - Patient Eligibility Screening Checklist Tool for Prescribers

  • Fact Check - Paxlovid

  • IDSA - Management of Drug Interactions with Paxlovid

  • NIH - Prior to prescribing Paxlovid.pdf

  • COVID-19 Therapeutics Drug-Drug Interactions - University of Liverpool

  • FDA EUA for Paxlovid Fact Sheet

• Special considerations

  • ACOG FAQs with comments on therapeutics in pregnancy and lactation

  • Select COVID-19 Therapeutics in Pregnancy and Lactating Mothers.pdf

Exposure, Quarantine, and Isolation

• CDC Quarantine and Isolation Calculator

• Definition of Exposed for COVID-19.pdf

• Isolation for COVID-19.pdf

• Quarantine for COVID-19.pdf

Testing

• Testing Supplies and Resources

  • COVIDtests.gov - Free at-home COVID-19 tests

  • Vermont Tesing

  • CVS

  • SVMC COVID-19 Resource Center

• Other Information

  • COVID-19 Testing Basics - FDA

  • COVID-19 Testing: What You Need to Know - CDC

  • Home testing FAQs - FDA

  • Self-testing videos - CDC

  • Testing for SARS-CoV-2 in Asymptomatic People.pdf

  • Testing for SARS-CoV-2 in Symptomatic People.pdf

  • Vermont Department of Health Testing Decision Tree

  • The Basics of Testing for the Virus - Table.pdf

Return to Work for Those Exposed

• Return to Work for Asymptomatic Unvaccinated Healthcare Personnel (HCP) Exposed to COVID-19 Outside of Healthcare Environment.pdf

• Return to Work for Asymptomatic Unvaccinated Healthcare Personnel (HCP) Exposed to COVID-19 Within the Healthcare Environment.pdf

• Return to Work For Asymptomatic Vaccinated Healthcare Personnel (HCP) Exposed to COVID-19.pdf

Return to Work for Those Infected

• Return to Work for Healthcare Personnel (HCP) with SARS-CoV-2 Infection.pdf
  

Return to School

• VCHIP Algorthms and Forms

• VCHIP - VT AAP - VT DoH Return to School and Daycare

• VAE

• 2022 COVID-19 Testing In Vermont Schools

• 2022 COVID-19 Testing In Vermont Schools FAQs

Return to Play

• VCHIP Medical Guideline for Return to Play

• American Academy of Pediatrics Return to Play Guidance

• American Academy of Pediatrics Return to Play Algorithm